Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
|
|
16.
|
Compound GW506U78 in refractory hematologic malignancies: relationship between cellular pharmacokinetics and clinical response. [electronic resource] by
- Gandhi, V
- Plunkett, W
- Rodriguez, C O
- Nowak, B J
- Du, M
- Ayres, M
- Kisor, D F
- Mitchell, B S
- Kurtzberg, J
- Keating, M J
Producer: 19981130
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 16
Availability: No items available.
|
|
17.
|
Phase I study of 506U78 administered on a consecutive 5-day schedule in children and adults with refractory hematologic malignancies. [electronic resource] by
- Kurtzberg, J
- Ernst, T J
- Keating, M J
- Gandhi, V
- Hodge, J P
- Kisor, D F
- Lager, J J
- Stephens, C
- Levin, J
- Krenitsky, T
- Elion, G
- Mitchell, B S
Producer: 20050624
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 23
Availability: No items available.
|